تقرير
Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities.
| العنوان: | Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities. |
|---|---|
| المؤلفون: | Das S; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Kelly D; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Moran B; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Han K; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Mulligan N; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Barrett C; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Buckley PG; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., McMahon P; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., McCaffrey J; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Van Essen HF; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Connor K; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Lambrechts D; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Ylstra B; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Gallagher WM; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., O'Connor DP; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium., Kelly CM; , , , , , , , , , , and , University College Dublin, Belfield; , , , and , Royal College of Surgeons in Ireland; , , , , , , and , Mater Misericordiae University Hospital; , Beaumont Hospital, Dublin, Ireland; and , Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and , Vesailus Research Center, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, Leuven, Belgium. |
| المصدر: | JCO precision oncology [JCO Precis Oncol] 2017 Jun 05; Vol. 1. Date of Electronic Publication: 2017 Jun 05 (Print Publication: 2017). |
| نوع المنشور: | Case Reports |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Alexandria, VA : American Society of Clinical Oncology, [2017]- |
| مستخلص: | Competing Interests: Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic AbnormalitiesThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or po.ascopubs.org/site/ifc.Sudipto DasHonoraria: Roche NimbleGenDeirdre KellyNo relationship to discloseBruce MoranNo relationship to discloseKathleen HanNo relationship to discloseNiall MulliganNo relationship to discloseCiara BarrettNo relationship to disclosePatrick G. BuckleyNo relationship to disclosePeter McMahonNo relationship to discloseJohn McCaffreyNo relationship to discloseHendrik F. Van EssenNo relationship to discloseKate ConnorNo relationship to discloseDiether LambrechtsNo relationship to discloseBauke YlstraNo relationship to discloseWilliam M. GallagherEmployment: OncoMark Leadership: OncoMark Stock and Other Ownership Interests: OncoMark Consulting or Advisory Role: Carrick Therapeutics Research Funding: Carrick Therapeutics Travel, Accommodations, Expenses: OncoMarkDarran P. O'ConnorNo relationship to discloseCatherine M. KellyNo relationship to disclose |
| References: | Endocr Pathol. 2010 Sep;21(3):178-85. (PMID: 20521125) J Clin Endocrinol Metab. 2008 Nov;93(11):4367-72. (PMID: 18765511) BMC Neurol. 2016 Dec 1;16(1):248. (PMID: 27905892) Biochem Biophys Res Commun. 2015 Apr 10;459(3):379-86. (PMID: 25727011) Cell. 2011 Jan 7;144(1):27-40. (PMID: 21215367) Ann Oncol. 2010 May;21 Suppl 5:v214-9. (PMID: 20555084) J Neurooncol. 2016 Jan;126(1):19-26. (PMID: 26476730) Int J Cancer. 2016 May 15;138(10):2322-33. (PMID: 26455580) Thromb Haemost. 2001 Sep;86(3):828-33. (PMID: 11583315) Thyroid. 2015 Jun;25(6):567-610. (PMID: 25810047) Cell. 2012 Jan 20;148(1-2):59-71. (PMID: 22265402) Sci Rep. 2016 Jul 14;6:29822. (PMID: 27412325) Cell. 2012 Jan 20;148(1-2):29-32. (PMID: 22265399) Eur J Endocrinol. 2012 May;166(5):847-54. (PMID: 22345297) Blood. 2011 Jul 21;118(3):675-8. (PMID: 21628407) J Gen Intern Med. 2006 Nov;21(11):C6-8. (PMID: 17026724) Ann Oncol. 2012 Jan;23(1):10-18. (PMID: 21471561) Genome Biol. 2011 Oct 19;12(10):R103. (PMID: 22014273) Nat Rev Cancer. 2012 Oct;12(10):663-70. (PMID: 22972457) Oncology. 2016;90(6):339-46. (PMID: 27207748) AJR Am J Roentgenol. 2013 Dec;201(6):W867-76. (PMID: 24261394) Genes Chromosomes Cancer. 2016 May;55(5):418-27. (PMID: 26841698) Leukemia. 2013 Dec;27(12):2376-9. (PMID: 23612016) Lancet Diabetes Endocrinol. 2016 Jan;4(1):64-71. (PMID: 26608066) Curr Opin Oncol. 2014 Jan;26(1):64-72. (PMID: 24305569) BMC Genomics. 2014 Jan 29;15:82. (PMID: 24476156) BMC Endocr Disord. 2013 Oct 21;13:48. (PMID: 24144365) Cell. 2013 Mar 14;152(6):1226-36. (PMID: 23498933) |
| تواريخ الأحداث: | Date Created: 20200911 Latest Revision: 20200928 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC7446351 |
| DOI: | 10.1200/PO.16.00063 |
| PMID: | 32913965 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2473-4284 |
|---|---|
| DOI: | 10.1200/PO.16.00063 |